ENTPD1 and cancer: Under pathological conditions, including hypoxia, ischemia, inflammation, or cancer, the concentration of adenosine increases rapidly as a consequence of massive extracellular dephosphorylation of ATP, mediated sequentially by CD39 and CD73 [40].